PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 11, 2016Clinical and Applied Thrombosis/Hemostasis56 citationsOpen Access

Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study

HKHandan İnönü KöseoğluAPAhmet Cemal PazarlıAKAsiye Kanbay

Structured PICO

Does the Monocyte Count/HDL Cholesterol Ratio predict Cardiovascular Disease in patients with Obstructive Sleep Apnea Syndrome?

P
Population
Patients with Obstructive Sleep Apnea Syndrome (OSAS)
I
Intervention
Monocyte Count/HDL Cholesterol Ratio (MHR)
O
Outcome
Cardiovascular Disease (CVD)

The Monocyte Count/HDL Cholesterol Ratio (MHR) may serve as a useful biomarker to predict cardiovascular disease in patients with obstructive sleep apnea syndrome.

Abstract

The MHR is strongly associated with CVD and the severity of OSAS and might be used as a biomarker to predict CVD in patients with OSAS.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Köseoğlu et al. (2016) studied this question.

synapsesocial.com/papers/69d574b56c5a512fd3f50edfhttps://doi.org/10.1177/1076029616677803
Ask AI
Helpful
Bookmark
Share
View Full Paper